Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.


Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Justin A. Renz MBA, CPA452017Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Jennifer Archibald-2006Chief Business Operations Officer
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,927,294 31,080,070 97.3% 0 0.0% 97.3%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 4,894,948 15.4%
Putnam Investment Management LLC 4,398,875 13.8%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,958,415 9.28%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 814,304 2.55%
AlphaOne Investment Services LLC 550,712 1.73%
Sabby Capital LLC 273,010 0.86%
Renaissance Technologies LLC 253,413 0.80%
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP47.47%149
BIOGEN8.26%60 012
CSL LIMITED26.27%45 698
ALEXION PHARMACEUTICALS7.72%29 594
GRIFOLS SA24.63%17 146
BIOMARIN PHARMACEUTICAL7.77%15 578
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%4 486
3SBIO INC25.79%3 103
ABCAM PLC31.29%2 675
JIANGXI BOYA BIO-PHARMACEUTICAL CO LTD--.--%2 049
HUGEL INC--.--%1 810
BIOTEST AG79.03%1 180
PHARMA MAR SA43.17%1 007
PROMETIC LIFE SCIENCES INC.-28.95%912
ANIKA THERAPEUTICS INC-2.14%702
SYROS PHARMACEUTICALS INC58.88%506
CHEMOCENTRYX INC35.81%484
SYNDAX PHARMACEUTICALS INC93.03%304
STRONGBRIDGE BIOPHARMA PLC181.25%239
KAMADA LTD.-5.93%203
CO DON AG237.73%189
Connections : Cardiome Pharma Corp
Nabriva Therapeutics AG
Kyowa Kirin International Plc
Zalicus Pharmaceuticals Ltd.
Trevi Therapeutics, Inc.
Quartet Medicine, Inc.
Premier's Technology Council
Virginia Center For Translational & Regulatory Sciences
Brighton Biotech, Inc.
Richardson Capital Ltd.
Michael Smith Foundation for Health Research
The Vancouver Symphony Foundation
Synereca Pharmaceuticals, Inc.
Advanced Applied Physics Solutions, Inc.
Pamlico BioPharma, Inc.
enGene, Inc.
Vancouver Symphony Orchestra
MedGenesis Therapeutix, Inc.
British Columbia Lottery Corp.
Vida Pharmaceuticals Pvt Ltd.
The 2010 Games Operating Trust
Kearny Venture Partners
Pacific Autism Family Centre Foundation
Blackthorn Therapeutics, Inc.
Correvio International SARL
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2017 People , Fundamentals and Ownership